MedTrace Logo

A Study for Absorption of Intranasal Epinephrine Compared to Conventional Intramuscular Epinephrine

NCT01432522 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2011-09-13

No results posted yet for this study

Summary

This study is a preliminary report of pharmacokinetic data of epinephrine administered via intranasal route (IN) comparing with intramuscular (IM) route in healthy adult volunteers.

Conditions

Interventions

DRUG

Epinephrine

1. Intranasal epinephrine 5 mg /spray 2. Intramuscular epinephrine 0.3 mg 3. Intranasal saline spray

Sponsors & Collaborators

  • Mahidol University

    collaborator OTHER

  • Siriraj Hospital

    lead OTHER

Principal Investigators

  • Pakit Vichyanond, MD. · Siriraj medical school, Mahidol Univrsity

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2011-08-31
Completion
2011-09-30

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01432522 on ClinicalTrials.gov